Urinary Bladder Neoplasms
"Urinary Bladder Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the URINARY BLADDER.
Descriptor ID |
D001749
|
MeSH Number(s) |
C04.588.945.947.960 C12.758.820.968 C12.777.829.813 C13.351.937.820.945 C13.351.968.829.707
|
Concept/Terms |
Urinary Bladder Neoplasms- Urinary Bladder Neoplasms
- Neoplasm, Urinary Bladder
- Urinary Bladder Neoplasm
- Neoplasms, Bladder
- Bladder Neoplasms
- Bladder Neoplasm
- Neoplasm, Bladder
- Bladder Tumors
- Bladder Tumor
- Tumor, Bladder
- Tumors, Bladder
Urinary Bladder Cancer- Urinary Bladder Cancer
- Cancer, Urinary Bladder
- Malignant Tumor of Urinary Bladder
- Cancer of the Bladder
- Bladder Cancer
- Bladder Cancers
- Cancer, Bladder
- Cancer of Bladder
|
Below are MeSH descriptors whose meaning is more general than "Urinary Bladder Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Urinary Bladder Neoplasms".
This graph shows the total number of publications written about "Urinary Bladder Neoplasms" by people in this website by year, and whether "Urinary Bladder Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 2 | 3 |
1996 | 2 | 0 | 2 |
1997 | 2 | 2 | 4 |
1998 | 2 | 1 | 3 |
1999 | 6 | 0 | 6 |
2000 | 7 | 1 | 8 |
2001 | 14 | 1 | 15 |
2002 | 9 | 0 | 9 |
2003 | 22 | 2 | 24 |
2004 | 15 | 2 | 17 |
2005 | 13 | 0 | 13 |
2006 | 26 | 1 | 27 |
2007 | 14 | 0 | 14 |
2008 | 26 | 0 | 26 |
2009 | 15 | 0 | 15 |
2010 | 18 | 2 | 20 |
2011 | 11 | 1 | 12 |
2012 | 11 | 1 | 12 |
2013 | 10 | 1 | 11 |
2014 | 16 | 0 | 16 |
2015 | 11 | 1 | 12 |
2016 | 17 | 0 | 17 |
2017 | 17 | 0 | 17 |
2018 | 8 | 0 | 8 |
2019 | 17 | 0 | 17 |
2020 | 14 | 1 | 15 |
2021 | 16 | 1 | 17 |
2022 | 9 | 0 | 9 |
2023 | 13 | 0 | 13 |
2024 | 16 | 3 | 19 |
To return to the timeline,
click here.
Below are the most recent publications written about "Urinary Bladder Neoplasms" by people in Profiles.
-
Integrating gene therapy into the treatment paradigm for non-muscle invasive bladder cancer. Expert Opin Biol Ther. 2025 Jan-Feb; 25(2):149-159.
-
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review. JCO Precis Oncol. 2024 Dec; 8:e2400470.
-
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma. Clin Genitourin Cancer. 2025 Feb; 23(1):102284.
-
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial. Nat Med. 2025 Jan; 31(1):176-188.
-
DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial. JCO Precis Oncol. 2024 Nov; 8:e2400287.
-
Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon a gene therapy in a murine bladder cancer model. Front Immunol. 2024; 15:1387229.
-
Impact of systemic therapy on clinical T1 small-cell neuroendocrine carcinoma of the bladder. ESMO Open. 2024 Nov; 9(11):103964.
-
Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum-containing chemotherapy: Post hoc analysis of KEYNOTE-052 and LEAP-011. Cancer. 2025 Jan 01; 131(1):e35601.
-
The evolving role of multidisciplinary teams in optimizing non-muscle invasive bladder cancer care. Expert Rev Anticancer Ther. 2024 Dec; 24(12):1203-1208.
-
Predicting Response to Intravesical Bacillus Calmette-Gu?rin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center Cohort. J Urol. 2025 Feb; 213(2):192-204.